REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jagadishwar Pharmaceutical Works Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jagadishwar Pharmaceutical Works Limited Profile Updated: July 22, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Jagadishwar Pharmaceutical Works Limited is a company based in India, with its head office in Guwahati. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on November 20, 1987.

Legal Address
205, Haribol Roy Market,A.T.Road
Guwahati; Assam; Postal Code: 781001

Contact Details: Purchase the Jagadishwar Pharmaceutical Works Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Jagadishwar Pharmaceutical Works Limited report to view the information.
Registered Capital:
Purchase the Jagadishwar Pharmaceutical Works Limited report to view the information.
Financial Auditors:
Purchase the Jagadishwar Pharmaceutical Works Limited report to view the information.
Incorporation Date:
November 20, 1987
Key Executives
Purchase this report to view the information.
Director & Member
Purchase this report to view the information.
Director & Member
Purchase this report to view the information.
Director & Member
Ownership Details
Purchase this report to view the information.
89.62%
Purchase this report to view the information.
5.72%
Purchase this report to view the information.
4.66%
Company Performance
Financial values in the chart are available after Jagadishwar Pharmaceutical Works Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Total Operating Revenue
37.14%▲
Operating Profit
86.32%▲
EBITDA
86.32%▲
Net Profit/Loss for the Period
89.53%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo